Jacqueline S Garcia

53PUBLICATIONS
332CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsGene and molecular therapyHaematological tumoursMolecular medicine
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (53)

|Sep 25, 2026
Venetoclax plus Inotuzumab Ozogamicin for Relapsed and Refractory Acute Lymphoblastic Leukemia.

|Sep 02, 2026
Therapy-persistent leukemia is selectively vulnerable to SLC23A1 restoration via targeting KHSRP.

|Jul 29, 2026
Venetoclax and hypomethylating agents versus other therapies: an international, multicenter, retrospective cohort chart review study.

|Jul 07, 2026
Tagraxofusp, Azacitidine, and Venetoclax in Blastic Plasmacytoid Dendritic Cell Neoplasm.

|Jun 30, 2026
A phase 1b/2 study of ceralasertib, a selective inhibitor of ATR, in patients with relapsed or refractory MDS and CMML.

|May 26, 2026
Dual BCL-xL and BCL-2 Inhibition for Advanced Myeloid Neoplasms: A Phase I Dose-Escalation Study of Navitoclax, Venetoclax, and Decitabine.

Pageof 9

Frequent Collaborators

20 joint publications

Marlise R Luskin

15 joint publications

Daniel J DeAngelo

12 joint publications

Eric S Winer

10 joint publications

Shai Shimony